ArticleAmerican journal of respiratory and critical care medicine2023
Validation of Proposed Criteria for Progressive Pulmonary Fibrosis.
Open access · greenAbstract readMulticenter Study
In one paragraph
Article in American journal of respiratory and critical care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 3 pooled it
18.1field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
89 citing papers in PubMed, 3 syntheses or guidelines pooled it, 125 citations in OpenAlex.
- Incidence and influencing factors of progressive pulmonary fibrosis in connective tissue disease-associated interstitial lung disease: a systematic review and meta-analysis.Frontiers in immunology · 2026Pooled it
- Quantification of progressive pulmonary fibrosis by visual scoring of HRCT images: recommendations from Italian chest radiology experts.La Radiologia medica · 2025Guideline
- Comorbidities in the idiopathic pulmonary fibrosis and progressive pulmonary fibrosis trial population: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2025Pooled it
- Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trial.The European respiratory journal · 2026Trial
- Trial
- The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases.Arthritis care & research · 2026Review
- Contemporary Concise Review 2025: Interstitial Lung Disease.Respirology (Carlton, Vic.) · 2026Review
- The lupus damage index revision program: Results from the item generation and reduction phases.Lupus science & medicine · 2026Review
- Article
- Deep-Learning Algorithm Diagnostic Support for Usual Interstitial Pneumonia Pattern Recognition in Fibrotic Interstitial Lung Disease.Respirology (Carlton, Vic.) · 2026Article
- Protective effects of PRELP protein in a mouse model of pulmonary fibrosis.Respiratory research · 2026Article
- Progressive pulmonary fibrosis.European radiology · 2026Review
- e-Lung computed tomography biomarkers are associated with outcomes in fibrotic interstitial lung diseases.ERJ open research · 2026Article
- A syndromic framework for progressive pulmonary fibrosis.Respiratory research · 2026Review
- Multidisciplinary management of interstitial lung disease in autoimmune rheumatic diseases: an Italian Delphi consensus.Respiratory research · 2026Article
- Molecular endotypes predict differential response to immunosuppressant therapy in non-idiopathic pulmonary fibrosis interstitial lung disease.American journal of respiratory and critical care medicine · 2026Observational
- Fibroneer Trials: More than Meets the Eye.Tuberculosis and respiratory diseases · 2026Article
- Prioritizing Therapeutic Targets for Interstitial Lung Disease: A Causal Mediation Analysis.Research square · 2026Article
- Comprehensive characterisation of individuals with fibrotic interstitial lung disease: baseline insights from the INJUSTIS study.BMJ open respiratory research · 2026Observational
- Circulating biomarkers in subjects with progressive pulmonary fibrosis: data from the INBUILD trial.ERJ open research · 2026Article
29 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
14 authors at 6 institutions in 2 countries.
Janelle Vu PugashettiDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-8889-2757
Ayodeji AdegunsoyeSection of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois.
Zhe WuNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Cathryn T LeeSection of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois.
Anand SrikrishnanDivision of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; and.
Sahand GhodratiDivision of Pulmonary, Critical Care and Sleep Medicine, University of California, Davis, Davis, California.
Vivian VoDivision of Pulmonary, Critical Care and Sleep Medicine, University of California, Davis, Davis, California.
Elisabetta A RenzoniNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Athol U WellsNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Christine Kim GarciaDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Columbia University, New York, New York.ORCID 0000-0002-0771-1249
Felix ChuaNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Chad A NewtonDivision of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; and.
Philip L MolyneauxNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Justin M OldhamDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-4957-8869
Guy's and St Thomas' NHS Foundation Trust · GBThe University of Texas Southwestern Medical Center · USUniversity of California, Davis · USUniversity of Chicago · USUniversity of Michigan · USColumbia University · US
Funding
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5MPULMONARY CELLULAR AND MOLECULAR BIOLOGY TRAININGT32HL007749 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Robert Pickett Dickson · 1993 to 2026
$19.9MRESEARCH TRAINING IN RESPIRATORY BIOLOGYT32HL007605 · NHLBI · UNIVERSITY OF CHICAGO · PI Yun Fang, Gokhan M. Mutlu · 1985 to 2026
$18.1MPilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Briseis A Aschebrook-Kilfoy · 2017 to 2026
$13.6MTRAINING IN COMPARATIVE LUNG BIOLOGY AND MEDICINET32HL007013 · NHLBI · UNIVERSITY OF CALIFORNIA DAVIS · PI Elena Goncharova, Nicholas J. KENYON · 1985 to 2026
$10.1MPulmonary Fibrosis and Telomerase DysfunctionR01HL093096 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI GARCIA, CHRISTINE KIM · 2009 to 2024
$6.9MElucidating the Genomic Determinants of Outcomes in Idiopathic Pulmonary FibrosisK23HL138190 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OLDHAM, JUSTIN M · 2017 to 2021
$914kMolecular Markers of Idiopathic Pulmonary Fibrosis ProgressionK23HL148498 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI NEWTON, CHAD ALAN · 2020 to 2024
$891kImproving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic ClustersK23HL146942 · NHLBI · UNIVERSITY OF CHICAGO · PI ADEGUNSOYE, AYODEJI · 2020 to 2024
$810kDerivation and validation of a clinical-molecular signature to predict fibrotic progression and treatment response in patients with autoimmune interstitial lung diseaseR56HL158935 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI OLDHAM, JUSTIN M · 2021 to 2021
$400kNCATS NIH HHS UL1 TR001105NHLBI NIH HHS K23 HL138190NHLBI NIH HHS K23 HL146942NHLBI NIH HHS K23HL146942NHLBI NIH HHS K23 HL148498NHLBI NIH HHS K23HL148498NHLBI NIH HHS R01 HL093096NHLBI NIH HHS R01HL093096NHLBI NIH HHS R56 HL158935NHLBI NIH HHS T32 HL007013NHLBI NIH HHS T32HL007013NHLBI NIH HHS T32 HL007605NHLBI NIH HHS T32 HL007749NIEHS NIH HHS P30 ES027792Versus Arthritis 20719
Abstract
PubMed holds no abstract for this paper.
Indexed as
Connective Tissue DiseasesIdiopathic Pulmonary FibrosisLung Diseases, InterstitialDisease ProgressionHumansPrognosisRetrospective Studiesidiopathic interstitial pneumoniaidiopathic pulmonary fibrosisinterstitial lung diseaseprogressive fibrosing interstitial lung diseaseprogressive pulmonary fibrosis
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.